$1.75
-0.06-3.31%
Pre-Market: 8:06 AM EDT
15 minutes delayed
BioRestorative Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioRestorative Therapies using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.50 | $-0.56 | 10.7 % |
Mar 2024 | 2024-05-14 | $-0.33 | $-0.51 | 35.3 % |
Dec 2023 | 2024-03-29 | $-0.57 | $-0.69 | 17.4 % |
Sep 2023 | 2023-11-13 | $-0.64 | $-0.68 | 5.88 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $89.10K | $10.00K | 791.0 % |
Mar 2024 | 2024-05-14 | $35.00K | $30.00K | 16.7 % |
Dec 2023 | 2024-03-29 | $19.30K | $10.00K | 93.0 % |
Sep 2023 | 2023-11-13 | $30.70K | $30.00K | 2.33 % |
BioRestorative Therapies (BRTX) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.50, which beat the estimate of $-0.56.
The Actual Revenue was $89.1K, which beat the estimate of $10K.
Browse earnings estimates, EPS, and revenue on all stocks.